Meeting highlights from the CHMP – 12-15 September 2022 16 September 2022 All news EU-Meeting-highlights-from-the-CHMP-12-15-September-2022-1Télécharger
Final programming Document 13 September 2022 All news https://www.ema.europa.eu/en/documents/report/final-programming-document-2022-2024_en.pdf
Guidance on releasing information from adverse reaction and medical device incident reports to the public 9 September 2022 All news Canada-Guidance-on-releasing-information-from-AR-and-MDI-reports_Aug2022-1Télécharger
Sweden: Developments regarding the monitoring of adverse events 5 September 2022 All news Sweden-Developments-regarding-the-monitoring-of-adverse-events_-16Aug2022-1Télécharger
Guidance for applicants/MAHs 2 September 2022 All news EU-Guidance-for-applicants_MAHs-involved-in-GMP-and-GCP-inspections-co-ordinated-by-EMA_-V3.0-2Télécharger
UK : Decommission of eSUSAR 26 August 2022 All news UK-Decommission-of-eSUSAR-MHRA-Inspectorate_03Aug2022-1Télécharger
Hong Kong: drug safety_requirements for decalaration 22 August 2022 All news Hong-Kong-Reporting_Requirement_Jun2022-1Télécharger
Austria : FAQ Pharmacovigilance 19 August 2022 All news Austria-FAQ-Pharmacovigilance-BASG_updated-11Aug2022-1Télécharger
Switzerland : safety of medicines 16 August 2022 All news Switzerland-BW101_20_002e_MB-Safety-of-Medicines_Jul2022-1Télécharger
